دورية أكاديمية
Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular Lithotripsy.
| العنوان: | Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular Lithotripsy. |
|---|---|
| المؤلفون: | Butala NM; Rocky Mountain Regional VA Medical Center, Aurora, Colorado.; University of Colorado School of Medicine, Aurora, Colorado., Waldo SW; Rocky Mountain Regional VA Medical Center, Aurora, Colorado.; University of Colorado School of Medicine, Aurora, Colorado.; VA CART Program, Office of Quality and Patient Safety, Washington, DC., Secemsky EA; Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Kennedy KF; University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute, Kansas City, Missouri., Spertus JA; University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute, Kansas City, Missouri., Rymer JA; Duke University School of Medicine, Durham, North Carolina., Rao SV; NYU Langone Health System, New York, New York., Messenger JC; University of Colorado School of Medicine, Aurora, Colorado., Yeh RW; Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts. |
| المصدر: | Journal of the Society for Cardiovascular Angiography & Interventions [J Soc Cardiovasc Angiogr Interv] 2024 Jan 22; Vol. 3 (2), pp. 101254. Date of Electronic Publication: 2024 Jan 22 (Print Publication: 2024). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419271306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-9303 (Electronic) Linking ISSN: 27729303 NLM ISO Abbreviation: J Soc Cardiovasc Angiogr Interv Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [New York] : Elsevier Inc., [2022]- |
| مستخلص: | Background: Calcified coronary lesions are a challenge for percutaneous coronary interventions (PCIs). Coronary intravascular lithotripsy (IVL) is a novel calcium modification technology approved for commercial use in February 2021, but little is known about its uptake in US clinical practice. Methods: We described trends in use of calcium modification strategies, variation in use across hospitals, and predictors of calcium modification and IVL use in PCI. We included National Cardiovascular Data Registry CathPCI Registry patients who underwent PCI between April 1, 2018, and December 31, 2022. We examined trends and hospital variation in calcium modification and IVL use. We used multivariate hierarchical logistic regression to identify predictors of calcium modification and IVL use at hospitals in 2022. Results: Of 2,733,494 PCIs across 1676 hospitals over 4.75 years, 11.4% were performed with calcium modification. Coronary IVL use increased rapidly from 0% of PCIs in Q4 2020 to 7.8% of PCIs in Q4 2022, which was accompanied by an overall increase in use of all calcium modification strategies (11.1%-16.0%) during this period with a slight corresponding decrease in coronary atherectomy use (5.4%-4.4%). In 2022, there was wide variation in IVL use across hospitals (median, 3.86%; IQR, 0%-8.19%), with IVL being the most common calcium modification strategy in 48% of hospitals. The treating hospital was the strongest predictor of calcium modification (median odds ratio [OR], 2.49; 95% CI, 2.40-2.57) and IVL use (median OR, 2.89; 95% CI, 2.74-3.04). Conclusions: IVL has rapidly changed the landscape of calcium modification use for PCI, although there remains wide variation across hospitals. |
| References: | Catheter Cardiovasc Interv. 2016 Mar;87(4):691-700. (PMID: 26525804) J Geriatr Cardiol. 2015 Mar;12(2):174-84. (PMID: 25870621) Circ Cardiovasc Interv. 2016 Mar;9(3):e003070. (PMID: 26957417) JACC Cardiovasc Interv. 2020 Jun 22;13(12):1417-1428. (PMID: 32553329) J Am Coll Cardiol. 2022 Jan 18;79(2):197-215. (PMID: 34895951) Circ Cardiovasc Interv. 2018 Oct;11(10):e007415. (PMID: 30354632) J Invasive Cardiol. 2016 Apr;28(4):160-7. (PMID: 26301561) JACC Cardiovasc Interv. 2021 Jun 28;14(12):1386-1388. (PMID: 34167685) JACC Cardiovasc Interv. 2021 Jun 28;14(12):1275-1292. (PMID: 34167671) JACC Cardiovasc Interv. 2013 Jan;6(1):10-9. (PMID: 23266232) Circ Cardiovasc Interv. 2020 Feb;13(2):e008239. (PMID: 31973557) Heart. 2013 Mar;99(5):297-303. (PMID: 23322530) Curr Cardiol Rep. 2014;16(10):530. (PMID: 25135343) JACC Cardiovasc Interv. 2014 May;7(5):510-8. (PMID: 24852804) J Am Coll Cardiol. 2020 Dec 1;76(22):2635-2646. (PMID: 33069849) J Am Coll Cardiol. 2014 May 6;63(17):1703-14. (PMID: 24530667) JACC Cardiovasc Interv. 2018 May 14;11(9):879-888. (PMID: 29747919) Circulation. 2006 Jan 31;113(4):490-8. (PMID: 16449728) Cardiovasc Revasc Med. 2017 Jun;18(4):261-264. (PMID: 28162989) J Am Coll Cardiol. 2012 Oct 16;60(16):1484-8. (PMID: 22999725) |
| فهرسة مساهمة: | Keywords: atherectomy; calcified coronary lesions; calcium modification; intravascular lithotripsy; percutaneous coronary intervention |
| تواريخ الأحداث: | Date Created: 20240812 Latest Revision: 20240813 |
| رمز التحديث: | 20240813 |
| مُعرف محوري في PubMed: | PMC11308754 |
| DOI: | 10.1016/j.jscai.2023.101254 |
| PMID: | 39132220 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 2772-9303 |
|---|---|
| DOI: | 10.1016/j.jscai.2023.101254 |